Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Aug 13, 2020

SELL
$4.42 - $12.66 $77,279 - $221,347
-17,484 Closed
0 $0
Q2 2019

Jul 31, 2019

SELL
$3.59 - $4.3 $179,500 - $215,000
-50,000 Reduced 74.09%
17,484 $69,000
Q1 2019

May 10, 2019

BUY
$3.37 - $4.34 $176,871 - $227,780
52,484 Added 349.89%
67,484 $293,000
Q2 2018

Aug 02, 2018

BUY
$3.12 - $5.19 $46,800 - $77,850
15,000 New
15,000 $59,000
Q4 2017

Feb 12, 2018

SELL
$2.96 - $4.42 $148,000 - $221,000
-50,000 Closed
0 $0
Q3 2017

Nov 14, 2017

BUY
$3.98 - $4.36 $199,000 - $218,000
50,000
50,000 $206,000

Others Institutions Holding BCLI

About BRAINSTORM CELL THERAPEUTICS INC.


  • Ticker BCLI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 36,486,200
  • Market Cap $82.8M
  • Description
  • Brainstorm Cell Therapeutics Inc., a biotechnology company, engages in the development and commercialization of autologous cellular therapies for the treatment of neurodegenerative diseases. The company, through its NurOwn proprietary cell therapy platform, leverages cell culture methods to induce autologous bone marrow-derived mesenchymal stem ...
More about BCLI
Track This Portfolio

Track Cibc Private Wealth Group, LLC Portfolio

Follow Cibc Private Wealth Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cibc Private Wealth Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cibc Private Wealth Group, LLC with notifications on news.